A Systematic Review and Meta-analysis of the Therapeutic Effect of Acupuncture on Migraine

**Acupuncture as a Treatment for Migraine: A Comprehensive Analysis of 28 Clinical Trials**

Migraine is one of the most challenging and impactful neurological conditions of our time, affecting millions of people around the world. Characterized by intense, throbbing headaches, often accompanied by nausea, vomiting, and excessive sensitivity to light and sound, migraine can be extremely debilitating. The Global Burden of Disease Study 2016 ranked migraine as the sixth most disabling disease globally, evidencing its enormous impact for both individuals and society. The conventional treatments available, although they may provide relief, are frequently associated with significant side effects and may not be able to fully prevent attacks, especially when used over long periods.

This scenario has led researchers and healthcare professionals to investigate alternative and complementary therapies, with acupuncture being one of the most promising options due to its demonstrated efficacy in clinical studies and its favorable safety profile.

This study represents a comprehensive systematic review and meta-analysis that examined 28 randomized controlled trials to assess the efficacy and safety of acupuncture in the treatment of migraine. The researchers conducted extensive searches in eight major medical databases, including PubMed, Cochrane Library, Embase, and specialized Chinese databases, covering publications from January 2000 to March 2019. To ensure the quality of the research, only studies that followed rigorous criteria were included: patients with a clear diagnosis of migraine, treatment groups that received exclusively acupuncture, control groups that used sham acupuncture or conventional medications, and standardized assessments of outcomes using measures such as attack frequency, duration, pain intensity through the visual analog scale, and cerebral blood flow examinations. The final analysis included 2,874 patients distributed in three groups: 1,396 received real acupuncture, 865 used conventional medications, and 613 received sham acupuncture.

The results of this research were consistently favorable to acupuncture in multiple aspects. When compared with sham acupuncture, true acupuncture demonstrated statistically significant superiority in virtually all evaluated measures. Patients who received real acupuncture experienced an average reduction of 1.00 point in the monthly frequency of migraine attacks, an improvement that may seem modest numerically but represents substantial relief for those suffering from this condition. Pain intensity, measured by the visual analog scale where zero represents absence of pain and ten represents unbearable pain, showed an average reduction of 0.59 points in the acupuncture group compared with the group that received sham acupuncture.

In addition, the overall efficacy rate of treatment was significantly superior, with more patients experiencing clinically relevant improvement. When acupuncture was compared with conventional medications, the results were even more impressive, showing not only greater therapeutic efficacy but also a substantially better safety profile, with an adverse events rate of only 0.01% compared with the 11.39% observed in the medication group.

A particularly interesting finding was the analysis of cerebral blood flow through transcranial Doppler. Migraine is frequently associated with alterations in cerebral circulation, and the researchers found that acupuncture was superior to conventional medications in improving blood flow velocity in the major cerebral arteries. Specifically, there were significant improvements in the anterior, middle, and posterior cerebral arteries, suggesting that acupuncture may have direct beneficial effects on the vascular pathophysiology underlying migraine. This finding is important because it offers a possible scientific explanation for the therapeutic effects observed, going beyond simple symptomatic relief to address fundamental mechanisms of the disease.

The clinical implications of these findings are substantial for both patients and healthcare professionals. For patients, especially those suffering from side effects of conventional medications or who present an inadequate response to traditional treatments, acupuncture emerges as a viable and effective therapeutic option. The very low incidence of adverse effects makes acupuncture particularly attractive for long-term preventive use, a crucial consideration given that migraine is frequently a chronic condition that requires ongoing management. For healthcare professionals, these results suggest that acupuncture should be considered as an integral part of a multidisciplinary approach to migraine treatment, whether as primary or complementary therapy.

The evidence of improvement in cerebral circulation also suggests that acupuncture may have preventive benefits, potentially reducing not only the intensity and frequency of attacks but also modifying the underlying pathophysiological processes.

However, it is essential to recognize the important limitations of this analysis. Heterogeneity among studies was considerable, reflecting differences in the acupuncture protocols used, in the selection of specific points, in treatment duration, and in evaluation criteria. Most of the included studies had relatively small sample sizes, and few were conducted as multicenter studies, which may limit the generalization of the results. In addition, the nature of acupuncture makes it extremely difficult to conduct true double-blind studies, since the acupuncturist necessarily knows the type of treatment being administered.

Funnel plot analysis suggested the possible existence of publication bias, indicating that studies with negative results may have been less likely to be published. Despite these methodological limitations, the consistency of the favorable results for acupuncture across multiple outcomes and the magnitude of the effects observed strengthen the credibility of the conclusions.

This research represents a significant contribution to the evidence base on acupuncture in the treatment of migraine, convincingly demonstrating that this ancient therapy has measurable clinical efficacy and a favorable safety profile. The results support the use of acupuncture as a legitimate therapeutic option for patients with migraine, offering an alternative or complement to conventional pharmacological treatments. For future developments in the area, the researchers emphasize the need for prospective multicenter studies with larger samples and more standardized protocols, which could provide even more robust evidence and guide the development of more specific clinical guidelines for the use of acupuncture in migraine management.